A detailed history of Davis Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Davis Capital Management holds 5,840 shares of AMGN stock, worth $1.85 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares
5,840
Previous 5,791 0.85%
Holding current value
$1.85 Million
Previous $1.8 Billion 4.48%
% of portfolio
1.49%
Previous 1.56%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024

BUY
$309.38 - $337.38 $15,159 - $16,531
49 Added 0.85%
5,840 $1.88 Billion
Q2 2024

Jul 02, 2024

BUY
$262.75 - $319.31 $16,027 - $19,477
61 Added 1.06%
5,791 $1.8 Billion
Q1 2024

Apr 05, 2024

BUY
$268.87 - $324.56 $21,778 - $26,289
81 Added 1.43%
5,730 $1.62 Billion
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $1.44 Million - $1.62 Million
5,628 Added 26800.0%
5,649 $1.63 Billion
Q1 2020

May 13, 2020

BUY
$182.24 - $241.7 $3,827 - $5,075
21 New
21 $4,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $170B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Davis Capital Management Portfolio

Follow Davis Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Davis Capital Management with notifications on news.